Unveiling HLH/MAS
Unveiling HLH/MAS
Podcast Description
Join Michael Jordan (Cincinnati Children’s Hospital, Ohio, USA) and top experts as they explore secondary HLH/MAS. This podcast series unpacks recent diagnostic and treatment guidelines, while tackling the real-world challenges clinicians face. Gain practical insights and stay ahead in managing this complex and often misunderstood condition.
Podcast Insights
Content Themes
Focuses on the complexities of secondary HLH and MAS, featuring episodes that cover recent diagnostic guidelines, treatment strategies, and the multidisciplinary approach to care. Episodes discuss critical topics such as the role of EBV in HLH, first-line therapies like anakinra and corticosteroids, and emerging therapies, providing clinicians with practical insights and management strategies.
Join Michael Jordan (Cincinnati Children’s Hospital, Ohio, USA) and top experts as they explore secondary HLH/MAS. This podcast series unpacks recent diagnostic and treatment guidelines, while tackling the real-world challenges clinicians face. Gain practical insights and stay ahead in managing this complex and often misunderstood condition.
Episode 3. Michael Jordan welcomes Adi Zoref-Lorenz to discuss the evolving landscape for secondary HLH and MAS. They explore first-line therapies like anakinra and corticosteroids, the critical importance of identifying underlying triggers, and the value of multidisciplinary care. The episode also covers EBV–HLH, emerging therapies, and practical strategies to monitor complex cases.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.